Two Phase III trials found that apixaban was more effective for stroke prevention than either aspirin or warfarin in patients with atrial fibrillation (AF), with a similar (versus aspirin ...

we randomly assigned 5599 patients with atrial fibrillation who were at increased risk for stroke and for whom vitamin K antagonist therapy was unsuitable to receive apixaban (at a dose of 5 mg ...

did not receive at least one dose of a trial medication. Apixaban or aspirin was permanently discontinued during follow-up owing to the development of subclinical atrial fibrillation lasting more ...

The study included 1500 patients with atrial fibrillation who were randomised to apixaban versus parenteral heparin with warfarin. Apixaban was administered orally at a dose of 5 mg twice a day ...

Atrial fibrillation (AF ... Novel anticoagulants include dabigatran, rivaroxaban and apixaban. Based on the RE-LY study, a 150-mg dose of dabigatran as compared with warfarin was shown to reduce ...

The clot-inhibiting drug apixaban (trade name: Eliquis) has been approved in Germany since November 2012 for the prevention of embolism and stroke in adults with non-valvular atrial fibrillation.

In A-fib patients selected using established dose-reduction criteria, the 2.5-mg twice daily dose of apixaban (Eliquis; Bristol-Myers Squibb) provides protection against stroke and death versus ...

Apixaban is used to treat and prevent blood clots such as deep vein thrombosis and pulmonary embolism. It also helps to lower risk of stroke if you have atrial fibrillation without an artificial ...

For dialysis patients with atrial fibrillation ... systemic embolism. Apixaban, however, was associated with a significant 28% lower risk for major bleeding than warfarin. Dosage was an important ...

Discover comprehensive details about Apixaban, including its pronunciation, uses, dosage instructions ... and blood clots in patients with atrial fibrillation who have no problems with their ...

[hmicms_related_articles] In summary, standard-dose apixaban for the treatment of atrial fibrillation in patients with ESRD may result in lower rates of major bleeding, stroke, and death compared ...